School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Ebrahim Haroon MD

  • Department of Psychiatry and Behavioral Sciences
    Associate Professor
  • (404) 778-5526
  • eharoon@emory.edu
  • My Profile
  • Emory University School of Medicine
    Department of Psychiatry & Behavioral Sciences
    101 Woodruff Circle, Suite 6003
Head shot of Ebrahim Haroon

Academic Appointment

  • Assistant Professor, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine

Education

Degrees

  • M.B.B.S from Madurai University Medical College

Research

Focus

  • Identifying translational biomarkers to identify targeted clinical and molecular interventions.
  • Imaging brain responses to chronic, immune system dysfunction

    My work focuses on using cutting-edge neuroimaging methods to examine the link between immune dysregulation, brain glutamate changes, and behavioral disorders. My work has established that chronic immune activation in depression and other medical conditions are associated with glutamate increases in subcortical and cortical regions, which regulate hedonistic capacity, motivation, and arousal. My work is now focussed on linking above mechanisms to progressive neuropathology seen in some subjects with mood disorders.

Publications

  • The new normal: neural network adaptations in late-life depression.
    Neuropsychopharmacology
    06/20/2025 Authors: Haroon E; Miller AH
  • Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia.
    Neuropsychopharmacology
    04/24/2025 Authors: Goldsmith DR; Ning CS; Strauss GP; Gross RE; Cooper JA; Wommack EC; Haroon E; Felger JC; Walker EF; Treadway MT
  • Not All Neuroinflammation Is Created Equal: The Dual Nature of Astrogliosis.
    Biol Psychiatry Volume: 97 Page(s): 758 - 760
    04/15/2025 Authors: Haroon E; Felger JC; Miller AH
  • Designing Clinical Trials for an Inflammatory Subtype of Major Depressive Disorder.
    Biol Psychiatry
    04/10/2025 Authors: Miller AH; Felger JC; Haroon E
  • A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation.
    Mol Psychiatry Volume: 30 Page(s): 1407 - 1417
    04/01/2025 Authors: Treadway MT; Etuk SM; Cooper JA; Hossein S; Hahn E; Betters SA; Liu S; Arulpragasam AR; DeVries BAM; Irfan N
  • Lipids and C-reactive protein predict anhedonia and reward circuit functional connectivity responses to anti-cytokine and dopaminergic therapies in patients with depression.
    Compr Psychoneuroendocrinol Volume: 21 Page(s): 100284
    02/01/2025 Authors: Singh A; Bekhbat M; Goldsmith DR; Le N-A; Wommack EC; Li Z; Haroon E; Felger JC
  • Rewiring the brain: Inflammation's impact on glutamate and neural networks in depression.
    Neuropsychopharmacology Volume: 50 Page(s): 312 - 313
    11/01/2024 Authors: Haroon E; Miller AH
  • A randomized proof-of-mechanism trial of TNF antagonism for motivational anhedonia and related corticostriatal circuitry in depressed patients with high inflammation.

    03/05/2024 Authors: Treadway M; Etuk S; Cooper J; Hossein S; Hahn E; Betters S; Liu S; Arulpragasam A; DeVries B; Irfan N
  • A Chart-Stimulated Recall Activity to Assess Psychiatry Residents' Treatment-Based, Clinical Reasoning Skills.
    Acad Psychiatry Volume: 47 Page(s): 663 - 666
    12/01/2023 Authors: Rakofsky JJ; Stoddard HA; Haroon E; Hermida AP; Debrey SM; Crowell AL; Dunlop BW
  • Alterations of gray and white matter volumes and cortical thickness in treated HIV-positive patients.
    Magn Reson Imaging Volume: 95 Page(s): 27 - 38
    01/01/2023 Authors: Joy A; Nagarajan R; Daar ES; Paul J; Saucedo A; Yadav SK; Guerrero M; Haroon E; Macey P; Thomas MA
  • Immunometabolic Gene Pathways are Associated With Anhedonia and Altered Following a TNF-Alpha Antagonist in Patients With Depression and High Inflammation
    Volume: 47 Page(s): 232 - 232
    12/01/2022 Authors: Bekhbat M; Haroon E; Etuk S; Felger J; Miller A; Treadway M
  • From Blue to Gray: Inflammation, Aging and Neurodegeneration in Depression
    Volume: 47 Page(s): 246 - 247
    12/01/2022 Authors: Haroon E; Beltran D; Chen X; Wommack E; Roberts B; Qiu D; Goldstein F; Treadway M; Felger J; Miller A
  • Correction to: Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study.
    Mol Psychiatry Volume: 27 Page(s): 4122
    10/01/2022 Authors: Bekhbat M; Li Z; Mehta ND; Treadway MT; Lucido MJ; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study.
    Mol Psychiatry Volume: 27 Page(s): 4113 - 4121
    10/01/2022 Authors: Bekhbat M; Li Z; Mehta ND; Treadway MT; Lucido MJ; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Increased Effort Expenditure in Major Depression Following a TNF-Alpha Antagonist is Mediated by Change in Systemic Immunometabolism
    Volume: 46 Page(s): 239 - 239
    12/01/2021 Authors: Etuk S; Hahn E; DeVries B; Cooper J; Irfan N; Harrison D; Nuutinen M; Lal A; Arulpragasam A; Hossein S
  • Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming.
    Mol Psychiatry Volume: 26 Page(s): 7384 - 7392
    12/01/2021 Authors: Bekhbat M; Goldsmith DR; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Kynurenines increase MRS metabolites in basal ganglia and decrease resting-state connectivity in frontostriatal reward circuitry in depression.
    Transl Psychiatry Volume: 11 Page(s): 456
    09/04/2021 Authors: Chen X; Beltran DJ; Tsygankova VD; Woolwine BJ; Patel T; Baer W; Felger JC; Miller AH; Haroon E
  • Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications.
    Pharmacol Rev Volume: 73 Page(s): 1084 - 1117
    07/01/2021 Authors: Lucido MJ; Bekhbat M; Goldsmith DR; Treadway MT; Haroon E; Felger JC; Miller AH
  • Transcriptomic Signatures of Inflammation and Metabolic Reprogramming in Peripheral Blood Immune Cells are Implicated in Psychomotor Retardation in Depression
    Volume: 89 Page(s): S377 - S378
    05/01/2021 Authors: Bekhbat M; Goldsmith DR; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Neurobehavioral Phenotype of Kynurenine Metabolism in Depression
    Volume: 45 Page(s): 20 - 20
    12/01/2020 Authors: Haroon E
  • Associations among serum markers of inflammation, life stress and suicide risk in patients with major depressive disorder.
    J Psychiatr Res Volume: 129 Page(s): 53 - 60
    10/01/2020 Authors: Su Y-A; Lin J-Y; Liu Q; Lv X-Z; Wang G; Wei J; Zhu G; Chen Q-L; Tian H-J; Zhang K-R
  • Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia.
    Brain Behav Immun Volume: 88 Page(s): 161 - 165
    08/01/2020 Authors: Bekhbat M; Treadway MT; Goldsmith DR; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Protein and gene markers of metabolic dysfunction and inflammation together associate with functional connectivity in reward and motor circuits in depression.
    Brain Behav Immun Volume: 88 Page(s): 193 - 202
    08/01/2020 Authors: Goldsmith DR; Bekhbat M; Le N-A; Chen X; Woolwine BJ; Li Z; Haroon E; Felger JC
  • GENE SIGNATURES RELATED TO INSULIN SIGNALING AND TYROSINE METABOLISM DEFINE A SUB-TYPE OF DEPRESSION WITH ANHEDONIA AND HIGH CRP
    Volume: 82 Page(s): A197 - A197
    07/01/2020 Authors: Bekhbat M; Goldsmith DR; Treadway MT; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease.
    Neuropsychopharmacology Volume: 45 Page(s): 1086 - 1096
    06/01/2020 Authors: Hollander JA; Cory-Slechta DA; Jacka FN; Szabo ST; Guilarte TR; Bilbo SD; Mattingly CJ; Moy SS; Haroon E; Hornig M
  • What does plasma CRP tell us about peripheral and central inflammation in depression?
    Mol Psychiatry Volume: 25 Page(s): 1301 - 1311
    06/01/2020 Authors: Felger JC; Haroon E; Patel TA; Goldsmith DR; Wommack EC; Woolwine BJ; Le N-A; Feinberg R; Tansey MG; Miller AH
  • Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.
    Neuropsychopharmacology Volume: 45 Page(s): 998 - 1007
    05/01/2020 Authors: Haroon E; Welle JR; Woolwine BJ; Goldsmith DR; Baer W; Patel T; Felger JC; Miller AH
  • Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls.
    NPJ Schizophr Volume: 6 Page(s): 8
    04/01/2020 Authors: Goldsmith DR; Massa N; Pearce BD; Wommack EC; Alrohaibani A; Goel N; Cuthbert B; Fargotstein M; Felger JC; Haroon E
  • Why we do need a new gold open access journal called "Brain, behavior and immunity - Health".
    Brain Behav Immun Health Volume: 1 Page(s): 100001
    01/01/2020 Authors: Cattaneo A; Haroon E; Su K-P; Pariante CM
  • Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin.
    Lancet Psychiatry Volume: 7 Page(s): 93 - 108
    01/01/2020 Authors: Pollak TA; Lennox BR; Mller S; Benros ME; Prss H; Tebartz van Elst L; Klein H; Steiner J; Frodl T; Bogerts B
  • Why we do need a new gold open access journal called "Brain, Behavior, and Immunity - Health".
    Brain Behav Immun Volume: 83 Page(s): 1 - 2
    01/01/2020 Authors: Cattaneo A; Haroon E; Su K-P; Pariante CM
  • OXTR methylation modulates exogenous oxytocin effects on human brain activity during social interaction.
    Genes Brain Behav Volume: 19 Page(s): e12555
    01/01/2020 Authors: Chen X; Nishitani S; Haroon E; Smith AK; Rilling JK
  • Quinolinic Acid is Associated With Increased Basal Ganglia Glutamate and Anhedonia in Patients With Major Depression
    Volume: 44 Page(s): 148 - 148
    12/01/2019 Authors: Haroon E; Chen X; Baer W; Churillo K; Lis C; Woolwine B; Patel T; Felger J; Miller A
  • Severity of Psychomotor Retardation in Depression is Associated With mRNA Enrichment of Inflammatory and Metabolic Signaling Pathways
    Volume: 44 Page(s): 438 - 439
    12/01/2019 Authors: Goldsmith D; Bekhbat M; Woolwine B; Haroon E; Miller A; Felger J
  • Inflammation and decreased functional connectivity in a widely-distributed network in depression: Centralized effects in the ventral medial prefrontal cortex.
    Brain Behav Immun Volume: 80 Page(s): 657 - 666
    08/01/2019 Authors: Yin L; Xu X; Chen G; Mehta ND; Haroon E; Miller AH; Luo Y; Li Z; Felger JC
  • Inflammation Effects on Striatal Dopamine: Implications for Late Life Depression
    Volume: 85 Page(s): S42 - S43
    05/15/2019 Authors: Felger J; Haroon E; Miller A; Li Z
  • 'Inflammaging' in Depression - Morphological, Metabolic and Behavioral Consequences
    Volume: 85 Page(s): S93 - S94
    05/15/2019 Authors: Haroon E; Chen X; Kim AH; Woolwine B; Patel T; Felger JC; Miller A
  • FromInflammation to Anhedonia - Role of Glutamate, Regional Homogeneity and Network Dysfunction
    Volume: 85 Page(s): S59 - S59
    05/15/2019 Authors: Haroon E; Chen X; Kim AH; Woolwine B; Patel T; Li Z; Felger J; Miller A
  • Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.
    Brain Behav Immun Volume: 76 Page(s): 268 - 274
    02/01/2019 Authors: Goldsmith DR; Haroon E; Miller AH; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T
  • 'Inflammaging' Selectively Disrupts Structural and Functional Integrity of Subcortical Brain Structures to Precipitate Cognitive Impairments in Depression
    Volume: 43 Page(s): S300 - S301
    12/01/2018 Authors: Haroon E; Chen X; Patel T; Woolwine B; Hu X; Felger J; Miller A
  • Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression.
    Psychoneuroendocrinology Volume: 98 Page(s): 222 - 229
    12/01/2018 Authors: Bekhbat M; Chu K; Le N-A; Woolwine BJ; Haroon E; Miller AH; Felger JC
  • Intranasal oxytocin modulates neural functional connectivity during human social interaction.
    Am J Primatol Volume: 80 Page(s): e22740
    10/01/2018 Authors: Rilling JK; Chen X; Chen X; Haroon E
  • What's CRP got to do with it? Tackling the complexities of the relationship between CRP and depression.
    Brain Behav Immun Volume: 73 Page(s): 163 - 164
    10/01/2018 Authors: Felger JC; Haroon E; Miller AH
  • Inflammation negatively correlates with amygdala-ventromedial prefrontal functional connectivity in association with anxiety in patients with depression: Preliminary results.
    Brain Behav Immun Volume: 73 Page(s): 725 - 730
    10/01/2018 Authors: Mehta ND; Haroon E; Xu X; Woolwine BJ; Li Z; Felger JC
  • Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia.
    Transl Psychiatry Volume: 8 Page(s): 189
    09/10/2018 Authors: Haroon E; Chen X; Li Z; Patel T; Woolwine BJ; Hu XP; Felger JC; Miller AH
  • TNF- and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia.
    Schizophr Res Volume: 199 Page(s): 281 - 284
    09/01/2018 Authors: Goldsmith DR; Haroon E; Miller AH; Strauss GP; Buckley PF; Miller BJ
  • Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
    Psychoneuroendocrinology Volume: 95 Page(s): 43 - 49
    09/01/2018 Authors: Haroon E; Daguanno AW; Woolwine BJ; Goldsmith DR; Baer WM; Wommack EC; Felger JC; Miller AH
  • Temporal Profiles and Dose-Responsiveness of Side Effects with Escitalopram and Duloxetine in Treatment-Nave Depressed Adults.
    Behav Sci (Basel) Volume: 8
    07/17/2018 Authors: Polychroniou PE; Mayberg HS; Craighead WE; Rakofsky JJ; Aponte Rivera V; Haroon E; Dunlop BW
  • Inflammation Effects on Motivation and Motor Activity: Dopamine as Mediator and Treatment Target
    Volume: 83 Page(s): S62 - S63
    05/01/2018 Authors: Miller A; Haroon E; Felger J
  • Inflammation-associated Alterations in Corticostriatal Circuit Function in Breast Cancer: Relationship with Motivational and Motor Deficits and Fatigue
    Volume: 80 Page(s): A145 - A146
    04/01/2018 Authors: Felger J; Treadway MT; Li Z; Haroon E; Torres MA; Miller AH
  • Intranasal oxytocin, but not vasopressin, augments neural responses to toddlers in human fathers.
    Horm Behav Volume: 93 Page(s): 193 - 202
    07/01/2017 Authors: Li T; Chen X; Mascaro J; Haroon E; Rilling JK
  • Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.
    Am J Psychiatry Volume: 174 Page(s): 546 - 556
    06/01/2017 Authors: Dunlop BW; Kelley ME; Aponte-Rivera V; Mletzko-Crowe T; Kinkead B; Ritchie JC; Nemeroff CB; Craighead WE; Mayberg HS; PReDICT Team
  • Assessing Residents' Confidence in the Context of Pharmacotherapy Competence.
    Acad Psychiatry Volume: 41 Page(s): 350 - 353
    06/01/2017 Authors: Rakofsky JJ; Garlow SJ; Haroon E; Hermida AP; Young JQ; Dunlop BW
  • Within vs. between-subject effects of intranasal oxytocin on the neural response to cooperative and non-cooperative social interactions.
    Psychoneuroendocrinology Volume: 78 Page(s): 22 - 30
    04/01/2017 Authors: Chen X; Gautam P; Haroon E; Rilling JK
  • Arginine Vasopressin Effects on Subjective Judgments and Neural Responses to Same and Other-Sex Faces in Men and Women.
    Front Endocrinol (Lausanne) Volume: 8 Page(s): 200
    01/01/2017 Authors: Rilling JK; Li T; Chen X; Gautam P; Haroon E; Thompson RR
  • Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders.
    Mod Trends Pharmacopsychiatry Volume: 31 Page(s): 37 - 55
    01/01/2017 Authors: Haroon E; Miller AH
  • The Immunology of Behavior-Exploring the Role of the Immune System in Brain Health and Illness.
    Neuropsychopharmacology Volume: 42 Page(s): 1 - 4
    01/01/2017 Authors: Miller AH; Haroon E; Felger JC
  • Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.
    Curr Top Behav Neurosci Volume: 31 Page(s): 173 - 198
    01/01/2017 Authors: Haroon E; Miller AH
  • Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.
    Neuropsychopharmacology Volume: 42 Page(s): 193 - 215
    01/01/2017 Authors: Haroon E; Miller AH; Sanacora G
  • Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation.
    Neuropsychopharmacology Volume: 42 Page(s): 334 - 359
    01/01/2017 Authors: Miller AH; Haroon E; Felger JC
  • C-Reactive Protein Associations With Brain Structure and Function: Neural Markers of Pro-Inflammatory Risk for Depression Following Trauma Exposure
    Volume: 41 Page(s): S181 - S181
    12/01/2016 Authors: Fani N; Haroon E; Murray H; Ressler K; Michopoulos V
  • Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus.
    Physiol Behav Volume: 166 Page(s): 14 - 21
    11/01/2016 Authors: Felger JC; Haroon E; Woolwine BJ; Raison CL; Miller AH
  • Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression.
    Mol Psychiatry Volume: 21 Page(s): 1351 - 1357
    10/01/2016 Authors: Haroon E; Fleischer CC; Felger JC; Chen X; Woolwine BJ; Patel T; Hu XP; Miller AH
  • Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.
    Mol Psychiatry Volume: 21 Page(s): 1358 - 1365
    10/01/2016 Authors: Felger JC; Li Z; Haroon E; Woolwine BJ; Jung MY; Hu X; Miller AH
  • Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder.
    Brain Behav Immun Volume: 56 Page(s): 281 - 288
    08/01/2016 Authors: Goldsmith DR; Haroon E; Woolwine BJ; Jung MY; Wommack EC; Harvey PD; Treadway MT; Felger JC; Miller AH
  • Effects of oxytocin and vasopressin on the neural response to unreciprocated cooperation within brain regions involved in stress and anxiety in men and women.
    Brain Imaging Behav Volume: 10 Page(s): 581 - 593
    06/01/2016 Authors: Chen X; Hackett PD; DeMarco AC; Feng C; Stair S; Haroon E; Ditzen B; Pagnoni G; Rilling JK
  • DNA Methylation of OXTR Modulates the Effect of Oxytocin on the Neural Response to Positive and Negative Social Interactions
    Volume: 79 Page(s): 99S - 100S
    05/01/2016 Authors: Chen X; Nishitani S; Haroon E; Smith AK; Rilling J
  • Impact of Inflammation-induced Glutamate Increases on Neuroprogression Among Patients with Mood Disorders
    Volume: 79 Page(s): 310S - 310S
    05/01/2016 Authors: Haroon E; Miller AH
  • Inflammatory Markers are Associated with Decreased Psychomotor Speed in Patients with Major Depressive Disorder
    Volume: 79 Page(s): 53S - 53S
    05/01/2016 Authors: Goldsmith DR; Haroon E; Woolwine BJ; Jung MY; Wommack E; Harvey PD; Treadway MT; Felger JC; Miller AH
  • SLOWING, INFLAMMATION, AND DEPRESSION: IMPLICATIONS FOR ASSESSMENT AND TREATMENT OF OLDER DEPRESSED INDIVIDUALS
    Volume: 24 Page(s): S9 - S10
    03/01/2016 Authors: Brown P; Rutherford B; Haroon E; Roose S
  • Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans.
    Brain Imaging Behav Volume: 9 Page(s): 754 - 764
    12/01/2015 Authors: Feng C; Hackett PD; DeMarco AC; Chen X; Stair S; Haroon E; Ditzen B; Pagnoni G; Rilling JK
  • Inflammation-Related Decreases in Dopamine and Effects on Corticostriatal Reward Circuitry: Evidence from Humans and Non-Human Primates
    Volume: 40 Page(s): S37 - S37
    12/01/2015 Authors: Felger J
  • Inflammatory Cytokines Are Associated with Decreased Psychomotor Speed in Female, but Not Male, Patients with Major Depression
    Volume: 40 Page(s): S339 - S340
    12/01/2015 Authors: Goldsmith D; Haroon E; Woolwine B; Jung M; Wommack E; Felger J; Miller A
  • Conceptual Convergence: Increased Inflammation is Associated with Increased Basal Ganglia Glutamate in Patients with Major Depression
    Volume: 40 Page(s): S335 - S336
    12/01/2015 Authors: Haroon E; Fleischer C; Chen X; Felger J; Woolwine B; Hu X; Miller A
  • A common oxytocin receptor gene (OXTR) polymorphism modulates intranasal oxytocin effects on the neural response to social cooperation in humans.
    Genes Brain Behav Volume: 14 Page(s): 516 - 525
    09/01/2015 Authors: Feng C; Lori A; Waldman ID; Binder EB; Haroon E; Rilling JK
  • Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
    Brain Behav Immun Volume: 47 Page(s): 193 - 200
    07/01/2015 Authors: Weinberger JF; Raison CL; Rye DB; Montague AR; Woolwine BJ; Felger JC; Haroon E; Miller AH
  • Neuroticism modulates the effects of intranasal vasopressin treatment on the neural response to positive and negative social interactions.
    Neuropsychologia Volume: 73 Page(s): 108 - 115
    07/01/2015 Authors: Feng C; DeMarco AC; Haroon E; Rilling JK
  • Risk and Resilience: Animal Models Shed Light on the Pivotal Role of Inflammation in Individual Differences in Stress-Induced Depression.
    Biol Psychiatry Volume: 78 Page(s): 7 - 9
    07/01/2015 Authors: Felger JC; Haroon E; Miller AH
  • Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings.
    Brain Behav Immun Volume: 46 Page(s): 17 - 22
    05/01/2015 Authors: Haroon E; Felger JC; Woolwine BJ; Chen X; Parekh S; Spivey JR; Hu XP; Miller AH
  • Inflammatory cytokine effects on neurotransmitters, neurocircuits, and behavior in depression
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY Volume: 10 Page(s): S69 - S69
    04/01/2015 Authors: Felger JC; Haroon E; Woolwine BJ; Miller AH
  • Interaction of Aging and Inflammation is Associated with Increased Basal Ganglia Glutamate and Reduced Motivation and Motor Activity During Inteferon-Alpha Therapy
    Volume: 39 Page(s): S204 - S204
    12/01/2014 Authors: Haroon E; Felger JC; Woolwine BJ; Jung MY; Patel JD; Chen X; Hu XP; Miller AH
  • IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.
    Neuropsychopharmacology Volume: 39 Page(s): 1777 - 1785
    06/01/2014 Authors: Haroon E; Woolwine BJ; Chen X; Pace TW; Parekh S; Spivey JR; Hu XP; Miller AH
  • Heartsick: psychiatric and inflammatory implications of cerebromicrovascular disease.
    Int J Geriatr Psychiatry Volume: 29 Page(s): 577 - 585
    06/01/2014 Authors: Nemeth CL; Haroon E; Neigh GN
  • The Neurocircuitry of Inflammation in Depression
    Volume: 75 Page(s): 400S - 400S
    05/01/2014 Authors: Felger JC; Li Z; Haroon E; Brigitta G; Hu X; Miller A
  • Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interaction.
    Psychoneuroendocrinology Volume: 39 Page(s): 237 - 248
    01/01/2014 Authors: Rilling JK; DeMarco AC; Hackett PD; Chen X; Gautam P; Stair S; Haroon E; Thompson R; Ditzen B; Patel R
  • Increased Glutamate in the Dorsal Anterior Cingulate Cortex Is Associated with Anxiety Symptom Domain in MDD with High inflammation
    NEUROPSYCHOPHARMACOLOGY Volume: 38 Page(s): S222 - S223
    12/01/2013 Authors: Haroon E; Woolwine B; Chen X; Hu X; Miller AH
  • Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
    Brain Behav Immun Volume: 31 Page(s): 205 - 215
    07/01/2013 Authors: Mehta D; Raison CL; Woolwine BJ; Haroon E; Binder EB; Miller AH; Felger JC
  • Cytokine targets in the brain: impact on neurotransmitters and neurocircuits.
    Depress Anxiety Volume: 30 Page(s): 297 - 306
    04/01/2013 Authors: Miller AH; Haroon E; Raison CL; Felger JC
  • A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
    JAMA Psychiatry Volume: 70 Page(s): 31 - 41
    01/01/2013 Authors: Raison CL; Rutherford RE; Woolwine BJ; Shuo C; Schettler P; Drake DF; Haroon E; Miller AH
  • Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior.
    Neuropsychopharmacology Volume: 37 Page(s): 137 - 162
    01/01/2012 Authors: Haroon E; Raison CL; Miller AH
  • Evidence of early retinal microvascular changes in patients with type 2 diabetes and depression.
    Psychosom Med Volume: 72 Page(s): 535 - 538
    07/01/2010 Authors: Nguyen TT; Wong TY; Islam FMA; Hubbard L; Ajilore O; Haroon E; Darwin C; Esser B; Kumar A
  • Prefrontal myo-inositol concentration and visuospatial functioning among diabetic depressed patients.
    Psychiatry Res Volume: 171 Page(s): 10 - 19
    01/30/2009 Authors: Haroon E; Watari K; Thomas A; Ajilore O; Mintz J; Elderkin-Thompson V; Darwin C; Kumaran S; Kumar A
  • Brain Imaging in Psychopharmacology
    Page(s): 221 - 242
    01/01/2009 Authors: Haroon E; Pagnoni G; Heim CM; Berns GS; Mayberg HS
  • Neuroanatomical correlates of executive functioning in depressed adults with type 2 diabetes.
    J Clin Exp Neuropsychol Volume: 30 Page(s): 389 - 397
    05/01/2008 Authors: Watari K; Elderkin-Thompson V; Ajilore O; Haroon E; Darwin C; Pham D; Kumar A
  • Hippocampal morphology and distinguishing late-onset from early-onset elderly depression.
    Am J Psychiatry Volume: 165 Page(s): 229 - 237
    02/01/2008 Authors: Ballmaier M; Narr KL; Toga AW; Elderkin-Thompson V; Thompson PM; Hamilton L; Haroon E; Pham D; Heinz A; Kumar A
  • Is depression associated with microvascular disease in patients with type 2 diabetes?
    Depress Anxiety Volume: 25 Page(s): E158 - E162
    01/01/2008 Authors: Nguyen TT; Wong TY; Islam FMA; Hubbard L; Miller J; Haroon E; Darwin C; Esser B; Kumar A
  • Gray matter prefrontal changes in type 2 diabetes detected using MRI.
    J Magn Reson Imaging Volume: 27 Page(s): 14 - 19
    01/01/2008 Authors: Kumar A; Haroon E; Darwin C; Pham D; Ajilore O; Rodriguez G; Mintz J
  • Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy.
    Neuropsychopharmacology Volume: 32 Page(s): 1224 - 1231
    06/01/2007 Authors: Ajilore O; Haroon E; Kumaran S; Darwin C; Binesh N; Mintz J; Miller J; Thomas MA; Kumar A
  • Executive dysfunction and memory in older patients with major and minor depression.
    Arch Clin Neuropsychol Volume: 22 Page(s): 261 - 270
    02/01/2007 Authors: Elderkin-Thompson V; Mintz J; Haroon E; Lavretsky H; Kumar A
  • Cognitive function in adults with type 2 diabetes and major depression.
    Arch Clin Neuropsychol Volume: 21 Page(s): 787 - 796
    12/01/2006 Authors: Watari K; Letamendi A; Elderkin-Thompson V; Haroon E; Miller J; Darwin C; Kumar A
  • Executive dysfunction and memory in older patients with major and minor depression.
    Arch Clin Neuropsychol Volume: 21 Page(s): 669 - 676
    10/01/2006 Authors: Elderkin-Thompson V; Mintz J; Haroon E; Lavretsky H; Kumar A
  • Measurement of brain betabolites in type 2 diabetes and depression using proton magnetic resonance spectroscopy
    Volume: 30 Page(s): S94 - S94
    12/01/2005 Authors: Ajilore O; Haroon E; Darwin C; Binesh N; Thomas A; Kumaran S; Miller J; Kumar A
  • Cognitive function in middle-aged and older depressed adults with type-2 diabetes
    Volume: 29 Page(s): S149 - S150
    12/01/2004 Authors: Watari K; Letamendi A; Miller J; Haroon E; Kumar A
  • Brain metabolites and cognitive function among older depressed and healthy individuals using 2D MR spectroscopy.
    Neuropsychopharmacology Volume: 29 Page(s): 2251 - 2257
    12/01/2004 Authors: Elderkin-Thompson V; Thomas MA; Binesh N; Mintz J; Haroon E; Dunkin JJ; Kumar A
  • Cognitive function in middle-aged and older depressed adults with type-2 diabetes
    Volume: 19 Page(s): 938 - 939
    11/01/2004 Authors: Watari K; Letamendi A; Miller J; Haroon EA; Kumar A
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements